indicates that a confidential portion of the text of this agreement has been omitted and filed separately with the Securities and Exchange Commission RESEARCH, DEVELOPMENT AND OPTION AGREEMENT Research, Development and Option Agreement, dated as of...Research, Development and Option Agreement • March 19th, 1998 • Xoma Corp /De/ • Pharmaceutical preparations • California
Per the amended Colthurst License Agreement, a renewal annual license fee was payable commencing May 1998.Research, Development and Option Agreement • October 10th, 2003
In August 1994, the Company entered into a Research, Development and Option Agreement, with Edenland, Inc. and Mr. Prendergast. The agreement provided for the development of HE317 to a certain stage of development and granted the Company the right of first option on new products developed by Edenland, Inc. The agreement committed the Company to pay for certain development costs up to the amount of $3.0 million with certain contingencies for funding. In October 1996, the Company and Edenland, Inc. entered into an amendment, which accelerated the date that the $3.0 million payment for HE317 or other product development costs was to be made. The Company paid
ContractResearch, Development and Option Agreement • May 17th, 2004
